ClinicalTrialsFinder
RecruitingNCT06454838

Exercise Capacity Muscle Oxygenation and Arterial Stiffness in Children With Pulmonary Arterial Hypertension

Sponsor

Gazi University

Enrollment

26 participants

Start Date

Apr 30, 2024

Study Type

OBSERVATIONAL

Conditions

Pulmonary Arterial Hypertension

Summary

The primary aim is to evaluate pulmonary function, respiratory muscle strength, upper and lower extremity exercise capacity, muscle oxygenation, dyspnea, peripheral muscle strength, arterial stiffness, physical activity level and balance in children with pulmonary arterial hypertension and compare with age- and sex-matched healthy controls. The second aim is to investigate the relationship between upper extremity exercise capacity, arterial stiffness, respiratory and peripheral muscle strength

Eligibility

Min Age: 6 YearsMax Age: 18 Years

Inclusion Criteria7

  • Patients:
  • Between the ages of 6-18
  • Diagnosed with pulmonary arterial hypertension
  • Stability of clinical condition and receiving standard medical treatment
  • Healthy controls:
  • Between the ages of 6-18
  • Willing to participate in the study

Exclusion Criteria6

  • Patients:
  • Having any acute infection, orthopedic, neurological, cooperation, vision or hearing problems that may prevent during the measurements
  • Participated in a planned exercise program in a last three months
  • Healthy controls:
  • Having any acute or chronic illness
  • Active or ex-smoker

Locations(1)

Gazi University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit

Ankara, Çankaya, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06454838

Related Trials

A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension

NCT065543011 location

Spironolactone for Pulmonary Arterial Hypertension

NCT017126201 location

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

NCT0558771235 locations

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

NCT0721802963 locations

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

NCT068465545 locations